John A Katzenellenbogen

发表

Indazole estrogens: highly selective ligands for the estrogen receptor beta.

Fabio Stossi, F. Stossi, B. Katzenellenbogen, 2005, Journal of medicinal chemistry.

Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.

Christopher G Mayne, J. Katzenellenbogen, K. Carlson, 2010, Journal of medicinal chemistry.

Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.

Marco Macchia, Gabriella Ortore, Filippo Minutolo, 2003, Journal of medicinal chemistry.

The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

J. Katzenellenbogen, John A Katzenellenbogen, 2020, Nuclear medicine and biology.

7alpha- and 17alpha-substituted estrogens containing tridentate tricarbonyl rhenium/technetium complexes: synthesis of estrogen receptor imaging agents and evaluation using microPET with technetium-94m.

Michael J Welch, M. Welch, J. Katzenellenbogen, 2003, Bioorganic & medicinal chemistry.

Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors.

Michael J Welch, Ephraim E. Parent, M. Welch, 2005, Bioconjugate chemistry.

Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor.

Michael J Welch, C. Dence, M. Welch, 2007, Nuclear medicine and biology.

64Cu Core-labeled nanoparticles with high specific activity via metal-free click chemistry.

Karen L Wooley, Michael J Welch, Dexing Zeng, 2012, ACS nano.

Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor.

J. Katzenellenbogen, K. Carlson, John A Katzenellenbogen, 2003, Bioorganic & medicinal chemistry letters.

Directed evolution of specific receptor-ligand pairs for use in the creation of gene switches.

Huimin Zhao, Zhilei Chen, Karuppiah Chockalingam, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer

Farrokh Dehdashti, Hannah M Linden, Amy M Fowler, 2016, The Journal of Nuclear Medicine.

Novel Ligands that Function as Selective Estrogens or Antiestrogens for Estrogen Receptor-α or Estrogen Receptor-β.

B. Katzenellenbogen, J. Katzenellenbogen, B. Fink, 1999, Endocrinology.

Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

Michael J Welch, John A Katzenellenbogen, Jae Hak Lee, 2010, Bioconjugate chemistry.

Estrogen Receptors (cid:1) and (cid:2) as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding

Barry Komm, B. Komm, B. Katzenellenbogen, 2008 .

Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.

Fabio Stossi, F. Stossi, B. Katzenellenbogen, 2005, Bioorganic & medicinal chemistry.

Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions

Sung Hoon Kim, Daniel Henrion, Pierre Chambon, 2013, Proceedings of the National Academy of Sciences.

Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation

Sarat Chandarlapaty, Emad Tajkhorshid, Patrick R Griffin, 2016, eLife.

Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140.

Gary Hattersley, Chris P. Miller, Hillary Herendeen, 2011, ACS medicinal chemistry letters.

Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance

Sarat Chandarlapaty, Christopher G Mayne, B. Katzenellenbogen, 2018, Nature Reviews Cancer.

The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligands.

J. Katzenellenbogen, John A Katzenellenbogen, 2011, Journal of medicinal chemistry.

A new fluorescence complementation biosensor for detection of estrogenic compounds

Huimin Zhao, Huimin Zhao, J. Katzenellenbogen, 2011, Biotechnology and bioengineering.

Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer.

Dong Wook Kim, J. Katzenellenbogen, K. Carlson, 2006, Journal of medicinal chemistry.

Estrogen receptor β ligands: Recent advances and biomedical applications

Marco Macchia, Filippo Minutolo, B. Katzenellenbogen, 2011, Medicinal research reviews.